In another meth-analysis in 2017 that reviewed 36 studies, OR for IgA AGA, and tTG antibodies (± EMA) and positive biopsy-proven CDs in IBS patients compared to control group were 3.21, 2.75, and 4.48, respectively (34). This evidence concerns the gene TGM2 and cerebral creatine deficiency syndrome.